Tools
Stock profile

Evolent Health, Inc. (EVH)

EVH · Latest close $3.93 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$3.93
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
1
vs previous quarter

Evolent Health, Inc. (EVH) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $329.5K sold). Latest close $3.93 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Aug 26, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-329.5K
Fundamentals
Revenue · FY2025
Red flags
screens flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Engaged Capital — 1 tracked fund hold EVH. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 1 sale ($329.5K). Insider trading

Often held alongside

GARTNER INC (IT) · ICON PLC (ICLR) · IQVIA HOLDINGS INC. (IQV) · VSE CORP (VSEC) · Genpact LTD (G) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Engaged Capital9.22%5,563,912HELD Q3 filed Nov 16
Maverick Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -19.5% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

13.261.732024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding200 of 8,857 filers
Long-only filers among them199
Change vs 2026 Q1+14 net · 199 entered · 185 exited
Shares reported, all filers112,306,411
Reported value, all filers$605.9M

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryServices-Management Services (SIC 8741)
Revenue · FY2025$1.9B
Net income · FY2025$-534.5M
Total assets · FY2025$1.9B
Shares outstanding113,059,335
Market cap (at latest close)$444.3M

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 1, 2026.

Short interest

Shares short · Oct 15, 202611,901,743
Share of shares outstanding10.53%
Days to cover5.62

Shares short at recent settlements — Jul 31, 2026: 15.8M · Aug 14, 2026: 15.8M · Aug 31, 2026: 15.5M · Sep 15, 2026: 14.1M · Sep 30, 2026: 12.9M · Oct 15, 2026: 11.9M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 1, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 4 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 1, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($329.5K).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Aug 26, 2026McCarthy Daniel JosephPRESIDENTSell65,892$5.00$329.5KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 26, 2026Daniel McCarthyOfficer65,892$327.5KAug 26, 2026SEC filing
Feb 25, 2025DUFFY MARY BRIDGETDirector9,151$93.9KFeb 25, 2025SEC filing
Aug 23, 2024McCarthy Daniel JosephOfficer34,162$1.1MAug 22, 2024SEC filing
Aug 22, 2024Weinberg JonathanOfficer42,140$1.3MAug 22, 2024SEC filing
Aug 22, 2024Blackley SethOfficer187,904$5.6MAug 22, 2024SEC filing
Aug 22, 2024Rafferty Emily AnnOfficer8,861$265.6KAug 22, 2024SEC filing
Aug 22, 2024Johnson John PaulOfficer44,693$1.3MAug 22, 2024SEC filing
Dec 5, 2023Blackley SethOfficer141,000$3.7MDec 5, 2023SEC filing
Nov 15, 2023McCarthy Daniel JosephOfficer11,000$329.4KNov 15, 2023SEC filing
Oct 10, 2023Tutewohl SteveOfficer24,090$675.0KOct 10, 2023SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Sep 8, 2026Morgan StanleySC 13G/A3,034,5892.7%Aug 31, 2026SEC filing
Jul 17, 2026BlackRock Portfolio Management LLCSC 13G6,227,3555.5%Jun 30, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 13, 2026Eventide Asset Management, LLCSC 13G/A1,7130.0%Dec 31, 2025SEC filing
Feb 11, 2026Morgan StanleySC 13G/A9,097,8088.1%Dec 31, 2025SEC filing
Feb 5, 2026FMR LLCSC 13G/A750,886.960.7%Dec 31, 2025SEC filing
Jan 30, 2026The Vanguard GroupSC 13G/A8,914,0658.0%Dec 31, 2025SEC filing
Nov 14, 2025Durable Capital Partners LPSC 13G/A00.0%Sep 30, 2025SEC filing
Nov 14, 2025Eventide Asset Management, LLCSC 13G/A6,292,5115.4%Sep 30, 2025SEC filing
Nov 14, 2025Rubicon Fund II LPSC 13G5,032,468.74.5%Nov 13, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Services-Management Services (SIC 8741). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Red Flags

· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10

· Excess Accruals (Sloan) — Sloan accruals ratio beyond ±25%

Key figures

· Distress Risk (Altman Z″) — Z″-Score: -3.00 · Working capital / assets: 0.06 · Retained earnings / assets: -0.69 · EBIT / assets: -0.22 · Equity / liabilities: 0.28

· Excess Accruals (Sloan) — Accruals ratio: -30.2% · Net income: $-534.5M · Operating cash flow: $38.8M · Investing cash flow: $-233.0K

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q1, ranked #3 of 50.

Also held by the tracked funds that hold EVH — ranked by lift, the co-holding pattern described in Methodology: GARTNER INC (IT) · ICON PLC (ICLR) · IQVIA HOLDINGS INC. (IQV) · VSE CORP (VSEC) · Genpact LTD (G) · Medpace Holdings, Inc. (MEDP) · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) · PAYCHEX INC (PAYX).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 5, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 6, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jun 4, 20265.07 Submission of Matters to a Vote of Security HoldersSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

GARTNER INC (IT) · Track Record: how the signals scored · Practice timing on EVH

One email a week: the week’s new filings and research. Subscribe free

← EVER  ·  EVLV →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.